Bicycle Therapeutics BCYC
NASDAQ BCYC
$3.60 +0.06 (+1.84%)
At close: Oct 20, 2026 · 4:00 PM EDT

Bicycle Therapeutics (BCYC) Current Leases (2024 - 2025)

Updated

Bicycle Therapeutics' Current Leases came in at $205,000 for Q4 2025, up 17.1% from $175,000 a year earlier.

Analysis

Bicycle Therapeutics (BCYC) Current Leases (2024 - 2025) Analysis & Trends

Going back to Q3 2024, Bicycle Therapeutics' Current Leases data covers 5 quarters.

  • Going back by year, Current Leases was $175,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Bicycle Therapeutics 249.90 Mn -2.10 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 205,000.00
Jun 30, 2025 199,000.00
Mar 31, 2025 184,000.00
Dec 31, 2024 175,000.00
Sep 30, 2024 182,000.00
API Access

Bicycle Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=BCYC&period=max&api_key=YOUR_API_KEY